Race for Immunity: the Russian Stock Market during the COVID-19 Pandemic
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Suvanova, Kurkam | - |
dc.contributor.author | Kang, Hyoung-Goo | - |
dc.contributor.author | Kang, Chang-Mo | - |
dc.date.accessioned | 2023-10-04T06:58:41Z | - |
dc.date.available | 2023-10-04T06:58:41Z | - |
dc.date.created | 2023-05-22 | - |
dc.date.issued | 2023-09 | - |
dc.identifier.issn | 0012-8775 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/191698 | - |
dc.description.abstract | This paper evaluates the stock market performance in Russia during the COVID-19 pandemic from January 3, 2020, to April 30, 2021. The study shows daily abnormal returns of stocks declined on the day when the first coronavirus case was detected. The government’s actions in implementing lockdown restrictions and providing stimulus packages positively influenced the stock market. However, the early lifting of lockdowns sent a negative signal to investors. Despite the skepticism among the population toward the first coronavirus vaccine Sputnik V, the news of its registration, mass vaccination, and Russia’s “vaccine diplomacy” contributed to the stock market’s growth. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ROUTLEDGE JOURNALS | - |
dc.title | Race for Immunity: the Russian Stock Market during the COVID-19 Pandemic | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kang, Hyoung-Goo | - |
dc.contributor.affiliatedAuthor | Kang, Chang-Mo | - |
dc.identifier.doi | 10.1080/00128775.2023.2210099 | - |
dc.identifier.scopusid | 2-s2.0-85158150196 | - |
dc.identifier.wosid | 000982864000001 | - |
dc.identifier.bibliographicCitation | EASTERN EUROPEAN ECONOMICS, v.61, no.SI 5, pp.554 - 570 | - |
dc.relation.isPartOf | EASTERN EUROPEAN ECONOMICS | - |
dc.citation.title | EASTERN EUROPEAN ECONOMICS | - |
dc.citation.volume | 61 | - |
dc.citation.number | SI 5 | - |
dc.citation.startPage | 554 | - |
dc.citation.endPage | 570 | - |
dc.type.rims | ART | - |
dc.type.docType | Article in press | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Business & Economics | - |
dc.relation.journalWebOfScienceCategory | Economics | - |
dc.subject.keywordPlus | COVID-19 | - |
dc.subject.keywordPlus | health policy | - |
dc.subject.keywordPlus | immunity | - |
dc.subject.keywordPlus | market conditions | - |
dc.subject.keywordPlus | pandemic | - |
dc.subject.keywordPlus | stock market | - |
dc.subject.keywordPlus | vaccine | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | event study | - |
dc.subject.keywordAuthor | lockdown | - |
dc.subject.keywordAuthor | Russian stock market | - |
dc.subject.keywordAuthor | vaccine | - |
dc.identifier.url | https://www.tandfonline.com/doi/full/10.1080/00128775.2023.2210099 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.